After more than four years as president of Siemens Healthcare North America, Greg Sorensen will be stepping down from his position, according to an anonymous source with close knowledge of the situation.

DOTmed HCB News has reached out to Siemens, but media contacts have not yet returned comment.

Update [9/14/2015]: "After four and a half years, Dr. Gregory Sorensen will be stepping down as President and CEO of Siemens Healthcare North America effective October 1," a Siemens media representative told HCB News via e-mail.



Prior to taking a leadership position with Siemens, Sorensen spent nearly 25 years as a neuroradiologist at Massachusetts General Hospital. Many industry insiders credit the former Harvard Medical School student's front line hospital experience with improving communication between end user and OEM.

"Just as cancer isn't fought with a single weapon and relies instead on effective combinations of treatments — this drug, and that therapy — to make progress, our larger societal fight against cancer is no exception," Sorensen wrote in an article for the Huffington Post decrying insufficient funding for the National Institutes of Health federal research center.

In order to take advantage of the market potential in power generation and the oil and gas industries, Siemens AG, the Munich, Germany based parent company of Siemens Healthcare, chose to manage its health care business separately under the Siemens umbrella last year.

Siemens Healthcare generated revenue worth over $13 billion and profits of more than $2 billion in fiscal 2014 and has roughly 43,000 employees worldwide.

As the company continues restructuring efforts to grant greater autonomy to individual regions around the world, it is unclear what the impact of changing leadership will be.

Business Affairs Homepage